Dr. Muhamad Aly Rifai Elevated to Distinguished Fellow of the American Psychiatric Association

Highest APA membership bestowed on Dr. Rifai honor recognizes decades of leadership in psychiatry, research, education, patient advocacy, and innovation

EASTON, PA, March 08, 2026 /24-7PressRelease/ -- Muhamad Aly Rifai, MD, has been elevated to Distinguished Fellow of the American Psychiatric Association (APA), the highest membership honor bestowed by the APA on its members. The distinction recognizes psychiatrists whose peers acknowledge sustained and significant contributions to the profession through clinical excellence, leadership, teaching, scholarship, community service, and service to organized psychiatry.

For Dr. Rifai, the recognition marks the culmination of nearly three decades of commitment to psychiatry, medicine, and public service. A longtime member of the American Psychiatric Association for close to 30 years, he previously served as an Area 3 representative for Members in Training to the APA Assembly, represented the National Institute of Mental Health at the Washington Psychiatric Society, and became a Fellow of the American Psychiatric Association in 2009. He also served as President of the Lehigh Valley Psychiatric Society, where he advocated for community based psychiatric care, physician leadership, and access to treatment.

Dr. Rifai is a physician entrepreneur, psychiatrist, internist, and addiction medicine specialist whose career has spanned academic medicine, federal research, executive leadership, and front-line patient care. He is the founder, CEO, and chief medical officer of Blue Mountain Psychiatry in Pennsylvania. His professional profile highlights board certification in psychiatry, internal medicine, addiction medicine, and consultation liaison psychiatry, along with leadership in telepsychiatry, integrated care, and novel treatments for complex psychiatric illnesses. Earlier in his career, Dr. Rifai received the American Psychiatric Institute for Research and Education Janssen Scholarship for research on severe mental illness, an early signal of a career shaped by scholarship and innovation. His work went on to include research and national presentations on the psychiatric dimensions of hepatitis C, psychosomatic medicine, and integrated care models.

"This honor means a great deal to me because it comes from the profession I have served for most of my adult life," said Dr. Rifai. "Psychiatry gave me a mission. It gave me a platform to serve patients in pain, families in crisis, and communities in need. To be recognized as a Distinguished Fellow by the American Psychiatric Association is both humbling and deeply meaningful. I accept it with gratitude, and with renewed commitment to clinical excellence, innovation, ethical leadership, and advocacy for both patients and physicians."

Dr. Rifai's career has extended beyond clinical work into writing, education, and public advocacy. He is the author of Doctor Not Guilty, a memoir and policy focused work on medicine, due process, and physician justice, which a prior press release described as reaching number 1 Amazon positions in several legal and medical categories. He writes and speaks nationally on mental health, addiction, physician rights, digital psychiatry, and the future of evidence-based care.

Born in Aleppo, Syria, and later trained in the United States at the University of Virginia and the National Institutes of Health, Dr. Rifai has built a career defined by resilience, scholarship, and service. Across academic appointments, leadership roles, media appearances, and patient care initiatives, he has worked to advance a psychiatry that is rigorous, humane, and accountable. His professional platforms describe him as a practicing psychiatrist and internist, scientist and researcher, medical legal expert, and humanitarian.

The elevation to Distinguished Fellow places Dr. Rifai among a select group of psychiatrists recognized by their peers for excellence and enduring contributions to the field. According to the APA, Distinguished Fellowship honors psychiatrists who have made major contributions in at least five areas including administration, teaching, publications, volunteering, community involvement, and clinical excellence.

"As psychiatry faces rising complexity, workforce strain, addiction, suicide, treatment resistance, and widening social need, we need leadership that protects science, protects patients, and protects the integrity of the profession," Dr. Rifai said. "I see this recognition not as a finish line, but as a mandate to keep building."

Dr. Muhamad Aly Rifai is a multiple board-certified psychiatrist, internist, addiction medicine specialist, and consultation liaison psychiatrist. He is the founder and chief executive of Blue Mountain Psychiatry in Pennsylvania and a former president of the Lehigh Valley Psychiatric Society. He has served in academic, research, clinical, and executive roles and is known for work in telepsychiatry, addiction treatment, integrated care, and physician advocacy. He is the author of Doctor Not Guilty and a national voice on the intersection of medicine, justice, and mental health.

Website: https://bluepsychiatry.org

Read the full story here: https://www.24-7pressrelease.com/press-release/532533/dr-muhamad-aly-rifai-elevated-to-distinguished-fellow-of-the-american-psychiatric-association

Press Release Service and Press Release Distribution by 24-7 Press Release Newswire